California, USA - ICCBBA announces its plans to recruit an Executive Director, to replace Paul Ashford, who has indicated his intention to retire December 31, 2021.
In early 2021, the ICCBBA Board will be commencing an international search for an Executive Director who could join the organization from mid-year (to provide a six-month transition period). Mr. Ashford has successfully led ICCBBA working primarily from his office based in the UK, and this has helped to strengthen the international credentials of the organization.
“Mr. Ashford has made a tremendous contribution to the growth and success of ISBT 128 for Medical Products of Human Origin,” said Diane Wilson, Chairman of ICCBBA Board of Directors. “During his 16 year tenure, Mr. Ashford has built ICCBBA into a strong and resilient organization and we are looking forward to continued growth under new direction in the future.”
The position will be advertised in relevant publications and on the ICCBBA website - visit the career opportunities page for more info.
ICCBBA, the international standards organization responsible for the management and development of ISBT 128 Standard, is a Non-State actor in the official relations with the World Health Organization (WHO).
ISBT 128 is the global standard for the terminology, identification, coding and labeling of medical products of human origin (including blood, cell, tissue, milk, and organ products). It is widely used in more than 87 countries across six continents and disparate health care systems. It is widely endorsed by the professional community.